Adult Medicine PRN Focus Session — Building Immunity: A Guide to Managing Immune-Mediated Medications for the General Practitioner
Tuesday, November 14, 2023 from 1:15 PM to 2:45 PM CST at Lone Star Ballroom A4
Available for 1.50 hours of CPE credit
Activity Number: 0217-0000-23-124-L01-P
Activity Type: An Application-Based Activity
This educational session focuses on managing immune-mediated medications that are commonly used in the inpatient and outpatient settings, including biologic agents and intravenous immunoglobulin (IVIG). The session will highlight uncertainties that clinical pharmacists face while caring for patients receiving these medications and incorporate newer primary literature on these focus areas. Specific topics will include:
- Initiating and managing biologic agents, including optimal timing, starting doses, and monitoring (e.g. baseline laboratory values, adverse drug reactions (ADRs), and therapeutic drug monitoring)
- Managing patients who are undergoing surgery or have active infections and are prescribed biologic agents
- Managing patients who need to receive IVIG, including monitoring for ADRs.
The session will also identify health disparities that may impact the clinical utility of these agents and current barriers to their use. The target audience of this session is pharmacy personnel that practice in an inpatient or outpatient setting. The purpose of this session is to update adult medicine practitioners on current best practices in managing immune-mediated therapies in general medicine settings.
Faculty
![Haley N. Johnson, Pharm.D., BCPS Haley N. Johnson, Pharm.D., BCPS](/images/imis/2087596.png) | Moderator: Haley N. Johnson, Pharm.D., BCPS Title: Adult Medicine PRN Focus Session — Building Immunity: A Guide to Managing Immune-Mediated Medications for the General Practitioner Institution: St. Louis College of Pharmacy at University of Health Sciences and Pharmacy City/State: O Fallon, MO
|
Learning Objectives
1. Discuss optimal practices while initiating biologic agents.
2. Recommend appropriate monitoring parameters for biologic agents given a patient case.
3. Distinguish whether various biologic agents should be administered during acute infections or around surgical procedures.
4. Compare dosing recommendations for intravenous immunoglobulin based on indication.
5. Identify monitoring parameters for efficacy and safety of intravenous immunoglobulin therapy.
Initiating and Monitoring Biologic Agents1:15 PM to 1:45 PM ![Sheila M. Wilhelm, Pharm.D., FCCP, BCPS Sheila M. Wilhelm, Pharm.D., FCCP, BCPS](/images/imis/1967306.png) | Speaker: Sheila M. Wilhelm, Pharm.D., FCCP, BCPS Title: Initiating and Monitoring Biologic Agents Institution: Wayne State University City/State: Troy, MI View Biography |
|
Management of Biologic Agents in Perioperative Settings and Acute Infection1:45 PM to 2:15 PM ![David E. Nix, Pharm.D., FCCP, BCIDP, BCPS David E. Nix, Pharm.D., FCCP, BCIDP, BCPS](/images/imis/1870052.png) | Speaker: David E. Nix, Pharm.D., FCCP, BCIDP, BCPS Title: Management of Biologic Agents in Perioperative Settings and Acute Infection Institution: University of Arizona City/State: Tucson, AZ View Biography |
|
Administering and Monitoring Intravenous Immunoglobulin2:15 PM to 2:45 PM ![Nikitha R. Patel, Pharm.D., BCPS Nikitha R. Patel, Pharm.D., BCPS](/images/imis/2115042.png) | Speaker: Nikitha R. Patel, Pharm.D., BCPS Title: Administering and Monitoring Intravenous Immunoglobulin Institution: Hospital of the University of Pennsylvania City/State: Kendall Park, NJ View Biography |
|